European Journal of Pharmacology 1993: Vol 233 Index

13 Pages·1993·2.3 MB·English

European Journal of Pharmacology, 233 (1992) 305-307
© 1993 Elsevier Science Publishers B.V. All rights reserved 0014-2999 /93 /$06.00
Author index
Akeson, A.L., see French, J.F. (233) 109 Diederen, W., see Van Meel, J.C.A. (233) 295
Alary, C., see Gué, M. (233) 193 Doble, A., see Malgouris, C. (233) 29
Allen, R.D., see Ong, J. (233) 169 Doble, A., see Malgouris, C. (233) 37
Anelli, M., see Caccia, §. (233) 71 Domenici, M.R., Longo, R., Scotti de Carolis, A., Frank, C. and
Sagratella, S$
Badgery-Parker, T., see Burcher, E. (233) 201 Protective actions of 21-aminosteroids and MK-801 on hypoxia
Barr, G.A. and Wang, S induced electrophysiological changes in rat hippocampal slices
Behavioral effects of chronic cocaine treatment in the week-old (233) 291
rat pup (233) 143 Doods, H.N., see Van Meel, J.C.A. (233) 295
Batra, S., see Kostrzewska, A. (233) 127 Doolette, D.J., see Ong, J. (233) 169
Bittiger, H., see Olpe, H.-R. (233) 179 Dow, J., see Lukovic, L. (233) 63
Boeynaems, J.-M., Heilporn, S., Broeders, F. and Braekman, J.-C Duke, R.K., see Ong, J. (233) 169
Enhancement of the endothelial production of prostacyclin by
substituted derivatives of BAPTA-AM (233) 13 Egan, M.F., see Chrapusta, S.J. (233) 135
Bolkenius, F.N., see Lukovic, L. (233) 63 Ezra, D., see Shamiss, A. (233) 113
Bowen, W.D., see Horan, P.J. (233) 53
Bowlin, T.L., see French, J.F. (233) 109 Fang, L., see Horan, PJ. (233) 53
Braekman, J.-C., see Boeynaems, J.-M. (233) 13 Ferguson, R., see Horan, P.J. (233) 53
Brain, S.D., see Lawrence, E. (233) 243 Ferrarese, A., see Caccia, S. (233) 71
Broeders, F., see Boeynaems, J.-M. (233) 13 Ferrat, T., see Olpe, H.-R. (233) 179
Brugger, F., see Olpe, H.-R. (233) 179 Flamand, F., see Malgouris, C. (233) 29
Buéno, L., see Gué, M. (233) 193 Flamand, F., see Malgouris, C. (233) 37
Burcher, E., Badgery-Parker, T., Zeng, X.-P. and Lavielle, S$ Fracasso, C., see Caccia, §. (233) 71
Characterisation of a novel, selective radioligand, ['*1][Lys°, Frank, C., see Domenici, M.R. (233) 291
Tyr(I,)’,MeLeu’,Nle™ neurokinin A-(4-10), for the tachykinin French, J.F., Schroeder, K.K., Akeson, A.L., Dage, R.C. and Bowlin,
NK, receptor in rat fundus (233) 201 &r.L
Burks, T.F., see Horan, P_J. (233) 53 Identification of a specific receptor for interleukin-1 in vascular
smooth muscle cells: regulation by interleukin-1 and interleukin-6
Caccia, S., Anelli, M., Ferrarese, A., Fracasso, C. and Garattini, S$ (233) 109
The role of d-norfenfluramine in the indole-depleting effect of Froestl, W., see Olpe, H.-R. (233) 179
d-fenfluramine in the rat (233) 71 Fujishima, M., see Ooboshi, H. (233) 165
Cauley, R.K., see Chang, Y.-F. (233) 209 Fukunaga, Y., Mine, Y., Yoshikawa, S., Takeuchi, T., Hata, F. and
Chang, Y.-F., Wang, Y., Cauley, R.K. and Gao, X.-M Yagasaki, O
Chronic L-lysine develops anti-pentylenetetrazol tolerance and Role of prostacyclin in acetylcholine release from myenteric
reduces synaptic GABAergic sensitivity (233) 209 plexus of guinea-pig ileum (233) 237
Chihara, K., see Maeda, K. (233) 227
Chiu, S., see Mamelak, M. (233) 175 Gao, X.-M., see Chang, Y.-F. (233) 209
Chrapusta, $.J., Karoum, F., Egan, M.F. and Wyatt, RJ Garattini, S., see Caccia, S. (233) 71
Haloperidol and clozapine increase intraneuronal dopamine Gispen, W.-H., see Hamers, F.P.T. (233) 177
metabolism, but not y-butyrolactone-resistant dopamine release Glavin, G.B. and Szabo, S
(233) 135 Effects of the Ca** chelators EGTA and EDTA on ethanol- or
Cools, A.R., see Koene, P. (233) 151 stress-induced gastric mucosal lesions and gastric secretion (233)
Corbett, J.A., see Misko, T.P. (233) 119 269
Currie, M.G., see Misko, T.P. (233) 119 Greiner, K., see Olpe, H.-R. (233) 179
Grenhoff, J. and Svensson, T.H
Dage, R.C., see French, J.F. (233) 109 Prazosin modulates the firing pattern of dopamine neurons in rat
Davis, T.P., see Horan, P.J. (233) 53 ventral tegmental area (233) 79
De Jong, W., see Lukovic, L. (233) 63 Grisar, J.M., see Lukovic, L. (233) 63
De Lang, H., see De Wildt, D.J. (233) 157 Gué, M., Alary, C., Del Rio-Lacheze, C., Junien, J.L. and Buéno, I
Del Rio-Lacheze, C., see Gué, M. (233) 193 Comparative involvement of 5-HT,, 5-HT, and 5-HT, receptors
Devlin, T.M., see Von Lubitz, D.K.J.E. (233) 95 in stress-induced colonic motor alterations in rats (233) 193
De Wildt, D.J., Krugers, H., Kasbergen, C.M., De Lang, H. and
Versteeg, D.H.G Haensel, S.M., Mos, J., Van der Schoot, P. and Slob, A.K
The hemodynamic effects of y,-melanocyte-stimulating hormone Testosterone is required for the stimulatory effects of 8-OH-
and related melanotropins depend on the arousal potential of the DPAT on sexual behavior in castrated male rats (233) 187
rat (233) 157 Haigh, R., see Van Meel, J.C.A. (233) 295
306
Hamers, F.P.T., Pette, C., Neijt, J.P. and Gispen, W.-H. Lukovic, L., Petty, M.A., Bolkenius, F.N., Grisar, J.M., Dow, J. and
The ACTH-~4-9) analog, ORG 2766, prevents taxol-induced De Jong, W.
neuropathy in rats (233) 177 Protection of infarcted, chronically reperfused hearts by an a-
Haruno, A. and Hashimoto, K. tocopherol analogue (233) 63
Antiarrhythmic effects of bisaramil in canine models of ventricu- Lundberg, J.M., see Weitzberg, E. (233) 85
lar arrhythmia (233) 1 Lundquist, I., see Panagiotidis, G. (233) 285
Hashimoto, K., see Haruno, A. (233) |
Hata, F., see Fukunaga, Y. (233) 237 Maeda, K., Kawata, E., Sakai, K. and Chihara, K.
Heilporn, S., see Boeynaems, J.-M. (233) 13 Effects of putative cognitive function-enhancing drugs and
Hirose, H., see Noguchi, K. (233) 47 dopaminergic agents on somatostatin and neuropeptide Y in rat
Horan, P.J., Wild, K.D., Kazmierski, W.M., Ferguson, R., Hruby, brain (233) 227
V.J., Weber, S.J., Davis, T.P., Fang, L., Knapp, R.J., Yamamura, Malgouris, C., Flamand, F. and Doble, A.
H.1., Kramer, T.H., Burks, T.F., Bowen, W.D., Takemori, A.E. Autoradiographic studies of RP 62203, a potent 5-HT, receptor
and Porreca, F antagonist. In vitro and ex vivo selectivity profile (233) 29
Unexpected antinociceptive potency of cyclic [D-Tca' }]CTAP: po- Malgouris, C., Flamand, F. and Doble, A.
tential for a novel mechanism of action (233) 53 Autoradiographic studies of RP 62203, a potent 5-HT, receptor
Hruby, V.J., see Horan, P.J. (233) 53 antagonist. Pharmacological characterization of [*HJRP 62203
Huang, T.-F., see Teng, C.-M. (233) 7 binding in the rat brain (233) 37
Mamelak, M., Chiu, S. and Mishra, R.K.
Ibayashi, S., see Ooboshi, H. (233) 165 High- and low-affinity states of dopamine D, receptors in
Ihara, M., see Noguchi, K. (233) 47 schizophrenia (233) 175
Insel, T.R., see Winslow, J.T. (233) 101 McDaniel, M.L., see Misko, T.P. (233) 119
Ishikawa, K., see Noguchi, K. (233) 47 McKenzie, R.J., see Von Lubitz, D.K.J.E. (233) 95
Itoh, Y., see Takeda, Y. (233) 299 Mewett, K.N., see Ong, J. (233) 169
Iwamoto, Y., see Kamei, J. (233) 251 Mickel, S.J., see Olpe, H.-R. (233) 179
Iwata, K., see Toide, K. (233) 21 Mine, Y., see Fukunaga, Y. (233) 237
Misawa, M., see Kamei, J. (233) 251
Johnston, G.A.R., see Ong, J. (233) 169
Mishra, R.K., see Mamelak, M. (233) 175
Junien, J.L., see Gué, M. (233) 193
Misko, T.P., Moore, W.M., Kasten, T.P., Nickols, G.A., Corbett,
J.A., Tilton, R.G., McDaniel, M.L., Williamson, J.R. and Currie,
Kakei, M., see Nakashima, H. (233) 219 M.G
Kamei, J., Iwamoto, Y., Misawa, M., Nagase, H. and Kasuya, Y.
Selective inhibition of the inducible nitric oxide synthase by
Antitussive effect of B-endorphin is mediated by y-opioid recep- aminoguanidine (233) 119
tors, but not by «- or e-opioid receptors (233) 251 Miyamori, I., see Takeda, Y. (233) 299
Karoum, F., see Chrapusta, S.J. (233) 135 Montuschi, P., Preziosi, P. and Navarra, P.
Kasamatsu, K., see Kawabata, A. (233) 255
Interleukin-la and tumour necrosis factor inhibit rat gastric
Kasbergen, C.M., see De Wildt, D.J. (233) 157
fundus motility in vitro (233) 303
Kasten, T.P., see Misko, T.P. (233) 119
Moore, W.M., see Misko, T.P. (233) 119
Kasuya, Y., see Kamei, J. (233) 251
Mos, J., see Haensel, $.M. (233) 187
Kawabata, A., Kasamatsu, K. and Takagi, H.
L-Tyrosine-induced antinociception in the mouse: involvement of
central 5-opioid receptors and bulbo-spinal noradrenergic system Nagase, H., see Kamei, J. (233) 251
(233) 255 Nakashima, H., Kakei, M. and Tanaka, H
Kawata, E., see Maeda, K. (233) 227 Activation of the ATP-sensitive K* channel by decavanadate in
Kazmierski, W.M., see Horan, P.J. (233) 53 guinea-pig ventricular myocytes (233) 219
Kerr, D.LS., see Ong, J. (233) 169 Navarra, P., see Montuschi, P. (233) 303
Knapp, R.J., see Horan, P.J. (233) 53 Neijt, J.P., see Hamers, F.P.T. (233) 177
Ko, F.-N., see Teng, C.-M. (233) 7 Nickols, G.A., see Misko, T.P. (233) 119
Koene, P., Prinssen, E.P.M. and Cools, A.R. Nishikibe, M., see Noguchi, K. (233) 47
Involvement of the nucleus accumbens in oral behaviour in the Noguchi, K., Noguchi, Y., Hirose, H., Nishikibe, M., Ihara, M..,
freely moving rat (233) 151 Ishikawa, K. and Yano, M.
Kostrzewska, A., Laudanski, T. and Batra, S$ Role of endothelin ET, receptors in bronchoconstrictor and
Effect of ovarian steroids and diethyistilbestrol on the contractile vasoconstrictor responses in guinea-pigs (233) 47
responses of the human myometrium and intramyometrial arter- Noguchi, Y., see Noguchi, K. (233) 47
ies (233) 127
Kramer, T.H., see Horan, P.J. (233) 53 Olpe, H.-R., Steinmann, M.W., Ferrat, T., Pozza, M.F., Greiner, K..,
Krugers, H., see De Wildt, D.J. (233) 157 Brugger, F., Froestl, W., Mickel, S.J. and Bittiger, H.
The actions of orally active GABA, receptor antagonists on
Laudanski, T., see Kostrzewska, A. (233) 127 GABAergic transmission in vivo and in vitro (233) 179
Lavielle, S., see Burcher, E. (233) 201 Ong, J., Kerr, D.LS., Doolette, D.J., Duke, R.K., Mewett, K.N.,
Lawrence, E. and Brain, S.D. Allen, R.D. and Johnston, G.A.R.
Big endothelin-1 and big endothelin-3 are constrictor agents in R-(— )-8-phenyl-GABA is a full agonist at GABA, receptors in
the microvasculature: evidence for the local phosphoramidon- brain slices but a partial agonist in the ileum (233) 169
sensitive conversion of big endothelin-1 (233) 243 Ooboshi, H., Sadoshima, S., Ibayashi, S., Yao, H., Uchimura, H. and
Lee, S.-S., see Teng, C.-M. (233) 7 Fujishima, M.
Lin, R.C.-S., see Von Lubitz, D.K.J.E. (233) 95 Isradipine attenuates the ischemia-induced release of dopamine
Longo, R., see Domenici, M.R. (233) 291 in the striatum of the rat (233) 165
307
Pairet, M., see Van Meel, J.C.A. (233) 295 Teng, C.-M., Yu, S.-M., Lee, S.-S., Ko, F.-N., Su, M.-J. and Huang,
Panagiotidis, G., Stenstrém, A. and Lundquist, I. T.-F
Effects of adrenergic and cholinergic stimulation on islet Vasoconstricting effect in rat aorta caused by thaliporphine iso-
monoamine oxidase activity and insulin secretion in the mouse lated from the plant Neolitsea konishii K (233) 7
(233) 285 Tilton, R.G., see Misko, T.P. (233) 119
Pang, C.C.Y., see Wang, Y.-X. (233) 275 Toide, K., Shinoda, M., Takase, M., Iwata, K. and Yoshida, H.
Peleg, E., see Shamiss, A. (233) 113 Effects of a novel thyrotropin-releasing hormone analogue, JTP-
Pette, C., see Hamers, F.P.T. (233) 177 2942, on extracellular acetylcholine and choline levels in the rat
Petty, M.A., see Lukovic, L. (233) 63 frontal cortex and hippocampus (233) 21
Porreca, F., see Horan, P.J. (233) 53 Turconi, M., see Van Meel, J.C.A. (233) 295
Pozza, M.F., see Olpe, H.-R. (233) 179
Preziosi, P., see Montuschi, P. (233) 303
Uchimura, H., see Ooboshi, H. (233) 165
Prinssen, E.P.M., see Koene, P. (233) 151
Roffel, A.F., see Ten Berge, R.E.J. (233) 279 Van der Schoot, P., see Haensel, $.M. (233) 187
Rosenthal, T., see Shamiss, A. (233) 113 Van Meel, J.C.A., Diederen, W., Haigh, R., Wienen, W., Pairet, M.,
Riickert, N.G.H. and Schmidt, WJ Turconi, M. and Doods, H.N
The o@ receptor ligand 1,3-di-(2-toly)guanidine in animal models The novel 5-HT, receptor antagonist DAU 6285 antagonizes
of schizophrenia (233) 261 5-hydroxytryptamine-induced tachycardia in pigs (233) 295
Rudehill, A., see Weitzberg, E. (233) 85 Van Tol, H.H.M., see Seeman, P. (233) 173
Versteeg, D.H.G., see De Wildt, DJ. (233) 157
Sadoshima, S., see Ooboshi, H. (233) 165 Von Lubitz, D.K.J.E., McKenzie, R.J., Lin, R.C.-S., Devlin, T.M
Sagratella, S., see Domenici, M.R. (233) 291 and Skolnick, P
Sakai, K., see Maeda, K. (233) 227 MK-801 is neuroprotective but does not improve survival in
Schmidt, W.J., see Riickert, N.G.H. (233) 261 severe forebrain ischemia (233) 95
Schroeder, K.K., see French, J.F. (233) 109
Scotti de Carolis, A., see Domenici, M.R. (233) 291 Wang, S., see Barr, G.A. (233) 143
Seeman, P. and Van Tol, H.H.M. Wang, Y., see Chang, Y.-F. (233) 209
Dopamine D, receptors bind inactive (+ )-aporphines, suggesting Wang, Y.-X. and Pang, C.C.Y
neuroleptic role. Sulpiride not stereoselective (233) 173 Suppression by ethanol of pressor response caused by the inhibi-
Shamiss, A., Peleg, E., Rosenthal, T. and Ezra, D tion of nitric oxide synthesis (233) 275
The role of atrial natriuretic peptide in the diuretic effect of Weber, S.J., see Horan, P_J. (233) 53
Ca** entry blockers (233) 113 Weitzberg, E., Rudehill, A. and Lundberg, J.M
Shinoda, M., see Toide, K. (233) 21 Nitric oxide inhalation attenuates pulmonary hypertension and
Skolnick, P., see Von Lubitz, D.K.J.E. (233) 95 improves gas exchange in endotoxin shock (233) 85
Slob, A.K., see Haensel, $.M. (233) 187 Wienen, W., see Van Meel, J.C.A. (233) 295
Steinmann, M.W., see Olpe, H.-R. (233) 179 Wild, K.D., see Horan, P_J. (233) 53
Stenstrém, A., see Panagiotidis, G. (233) 285 Williamson, J.R., see Misko, T.P. (233) 119
Su, M.-J., see Teng, C.-M. (233) 7 Winslow, J.T. and Insel, T.R
Svensson, T.H., see Grenhoff, J. (233) 79 Effects of central vasopressin administration to infant rats (233)
Szabo, S., see Glavin, G.B. (233) 269 101
Wyatt, R.J., see Chrapusta, S.J. (233) 135
Takagi, H., see Kawabata, A. (233) 255
Takase, M., see Toide, K. (233) 21
Yagasaki, O., see Fukunaga, Y. (233) 237
Takeda, R., see Takeda, Y. (233) 299
Yamamura, H.1., see Horan, PJ. (233) 53
Takeda, Y., Itoh, Y., Yoneda, T., Miyamori, |. and Takeda, R
Yano, M., see Noguchi, K. (233) 47
Cyclosporine A induces endothelin-1 release from cultured rat
Yao, H., see Ooboshi, H. (233) 165
vascular smooth muscle cells (233) 299
Yoneda, T., see Takeda, Y. (233) 299
Takemori, A.E., see Horan, P.J. (233) 53
Yoshida, H., see Toide, K. (233) 21
Takeuchi, T., see Fukunaga, Y. (233) 237
Yoshikawa, S., see Fukunaga, Y. (233) 237
Tanaka, H., see Nakashima, H. (233) 219
Yu, S.-M., see Teng, C.-M. (233) 7
Ten Berge, R.EJ., Roffel, A.F. and Zaagsma, J
The interaction of selective and non-selective antagonists with
pre- and postjunctional muscarinic receptor subtypes in the guinea Zaagsma, J., see Ten Berge, R.E.J. (233) 279
pig trachea (233) 279 Zeng, X.-P., see Burcher, E. (233) 201

European Journal of Pharmacology, 233 (1993) 309-316
© 1993 Elsevier Science Publishers B.V. All rights reserved 0014-/2939 /9$069.0 0
Key word index
Acetylcholine d,l-Amphetamine
JTP-2942 (N*-((1S,2R)-2-methyl-4-oxycyclopentanecarbony]]-L- o Binding sites; DTG (1,3-di-42-tolyl)guanidine); Antipsychotics; Di-
histidyl-L-prolinamide); TRH (thyrotropin-releasing hormone); zocilpine; Animal models; (Rat) (Riickert, N.G.H. (233) 261)
Choline; Frontal cortex; Hippocampus; Microdialysis (Toide, K. (233)
21) Angiotensin Il
N°&-Nitro-L-arginine; Ethanol; Noradrenaline; Vasopressor; Brady-
Acetylcholine release cardia; Baroreflex (Wang, Y.-X. (233) 275)
OP-41483 (prostacyclin analog); Prostaglandin release; Myenteric
plexus (Fukunaga, Y. (233) 237) Animal models
o Binding sites; DTG (1,3-di-2-tolyl guanidine); Antipsychotics; d,I-
ACTH-(4-10) Amphetamine; Dizocilpine; (Rat) (Riickert, N.G.H. (233) 261)
Y¥2MSH (y>-melanocyte-stimulating hormone); Melanotropins;
Hemodynamics; Urethane anesthesia; Pentobarbital anesthesia; Ex- ANP (atrial natriuretic peptide)
citability; (Conscious rat) (De Wildt, DJ. (233) 157) Ca’* entry blockers; Verapamil; Felodipine; Nifedipine; Diuretic
effects (Shamiss, A. (233) 113)
a ,-Adrenoceptors
Burst firing; Idazoxan; Noradrenaline; Reserpine (Grenhoff, J. (233) Antiarrhythmic agents (class I)
79) Bisaramil; Arrhythmia (ventricular) (Haruno, A. (233) 1)
a -Adrenoceptor stimulation Antinociception
Islets of Langerhans; Monoamine oxidase activity; B-Adrenoceptor u-Opioid receptors; 5-Opioid receptors; Opioid receptor antago-
stimulation; Cholinergic stimulation; Insulin; Glucose; (Mouse) (Pan nists; Metabolism (Horan, P.J. (233) 53)
agiotidis, G. (233) 285)
L-Tyrosine (methyl ester); 5-Opioid receptors; Bulbo-spinal norad-
B-Adrenoceptor stimulation
renergic system (Kawabata, A. (233) 255)
Islets of Langerhans; Monoamine oxidase activity; a-Adrenoceptor
stimulation; Cholinergic stimulation; Insulin; Glucose; (Mouse) (Pan-
Antipsychotics
agiotidis, G. (233) 285)
o Binding sites; DTG (1,3-di-(2-tolyl guanidine), d,|l-Amphetamine;
Dizocilpine; Animal models; (Rat) (Riickert, N.G.H. (233) 261)
Adult respiratory distress syndrome (ARDS)
Nitric oxide (NO); Endotoxin shock; Pulmonary hypertension; En-
Antitussive effect
dothelin; Noradrenaline; Neuropeptide Y (Weitzberg, E. (233) 85)
Cough; 8-Endorphin; Opioid receptors (Kamei, J. (233) 251)
Affiliation
Vasopressin; Ultrasonic vocalization; Anxiety; Thermoregulation; Anxiety
Vasotocin (Winslow, J.T. (233) 101) Vasopressin; Ultrasonic vocalization; Thermoregulation; Affiliation;
Vasotocin (Winslow, J.T. (233) 101)
Affinity states
Schizophrenia; Dopamine D, receptors (Mamelak, M. (233) 175) Aorta (bovine)
Endothelial cells; Prostacyclin; Ca** indicators; Arachidonate
Amantadine metabolism (Boeynaems, J.-M. (233) 13)
Somatostatin; Neuropeptide Y; |-DOPA (I-dihydroxyphenylalanine),;
6-Hydroxydopamine; Bifemelane (Maeda, K. (233) 227) Aporphines
Dopamine D, receptors; Sulpiride (Seeman, P. (233) 173)
(51) AMIK (['?51}7-amino-8-iodo-ketanserin)
RP 62203; 5-HT, receptor antagonists; 5-HT (S-hydroxytryptamine, Arachidonate metabolism
serotonin); Autoradiography; [*H]Mesulergine (Malgouris, C. (233) Endothelial cells; Prostacyclin; Ca** indicators; Aorta (bovine)
29) (Boeynaems, J.-M. (233) 13)
Aminoguanidine Arrhythmia (ventricular)
Nitric oxide synthase; Selective inhibitor inducible (Misko, T.P. (233) Bisaramil; Antiarrhythmic agents (class 1) (Haruno, A. (233) 1)
119)
Autoradiography
21-Aminosteroids RP 62203; 5-HT, receptor antagonists; 5S-HT (S-hydroxytryptamine,
NMDA (N-methyl-D-aspartate); Lipid peroxidation; Hypoxia serotonin); ['IJAMIK ({'*I}7-amino-8-iodo-ketanserin); [*H]-
(Domenici, M.R. (233) 291) Mesulergine (Malgouris, C. (233) 29)
310
Baclofen Ca** entry blockers
B-Phenyl-GABA; GABA, receptors; Brain slices (rat); [eum ANP (atrial natriuretic peptide); Verapamil; Felodipine; Nifedipine;
(guinea-pig); (Agonist /partial agonist) (Ong, J. (233) 169) Diuretic effects (Shamiss, A. (233) 113)
Baroreflex Ca** indicators
N°&-Nitro-L-arginine; Ethanol; Angiotensin I]; Noradrenaline; Vaso- Endothelial cells; Prostacyclin; Aorta (bovine); Arachidonate
pressor; Bradycardia (Wang, Y.-X. (233) 275) metabolism (Boeynaems, J.-M. (233) 13)
Benzodiazepines Castration
GABA (y-aminobutyric acid); CNS (central nervous system) depres- Sexual behaviour; Ejaculation; 8-OH-DPAT (8-hydroxy-2-(di-n-pro-
sants; Seizure tolerance; Receptor coupling; Cl” channels (Chang, pylamino)tetralin); Testosterone; (Wistar rat) (Haensel, $.M. (233)
Y.-F. (233) 209) 187)
Bifemelane
Cerebral ischemia
Somatostatin; Neuropeptide Y; |-DOPA (I-dihydroxyphenylalanine);
Isradipine; Dopamine; Microdialysis; Ca?* channels (voltage-sensi-
Amantadine; 6-Hydroxydopamine (Maeda, K. (233) 227)
tive) (Ooboshi, H. (233) 165)
Big endothelin-1
Cheek pouch (hamster)
Big endothelin-3; Phosphoramidon; Microcirculation; Cheek pouch
Big endothelin-1; Big endothelin-3; Phosphoramidon; Microcircula-
(hamster); Skin blood flow (rat) (Lawrence, E. (233) 243)
tion; Skin blood flow (rat) (Lawrence, E. (233) 243)
Big endothelin-3
Big endothelin-1; Phosphoramidon; Microcirculation; Cheek pouch Choline
(hamster); Skin blood flow (rat) (Lawrence, E. (233) 243) JTP-2942 (N*-[(1S,2R)-2-methyl-4-oxycyclopentanecarbony]l]-L-
histidyl-L-prolinamide); TRH (thyrotropin-releasing hormone);
o Binding sites Acetylcholine; Frontal cortex; Hippocampus; Microdialysis (Toide,
DTG (1,3-di-(2-tolyl)guanidine); Antipsychotics; d,!-Amphetamine; K. (233) 21)
Dizocilpine; Animal models; (Rat) (Riickert, N.G.H. (233) 261)
Cholinergic neurotransmission
Bisaramil Muscarinic M, receptors; Muscarinic M, receptors; Trachea
Antiarrhythmic agents (class I); Arrhythmia (ventricular) (Haruno, (guinea-pig); Muscarinic receptor antagonists; Electrical field stimu-
A. (233) 1) lation (Ten Berge, R.E.J. (233) 279)
BQ-123 Cholinergic stimulation
Endothelin; [Ala'*''>jendothelin-1; Bronchoconstriction; Hyper- Islets of Langerhans; Monoamine oxidase activity; a-Adrenoceptor
tension; (Receptor subtype) (Noguchi, K. (233) 47) stimulation; B-Adrenoceptor stimulation; Insulin; Glucose; (Mouse)
(Panagiotidis, G. (233) 285)
Bradycardia
N°-Nitro-L-arginine; Ethanol; Angiotensin II; Noradrenaline; Vaso- Cl~ channels
pressor; Baroreflex (Wang, Y.-X. (233) 275) GABA (y-aminobutyric acid); Benzodiazepines; CNS (central ner-
vous system) depressants; Seizure tolerance; Receptor coupling
Brain autoradiography (Chang, Y.-F. (233) 209)
(SHJRP 62203 binding sites; 5-HT, receptor antagonists (Malgouris,
C. (233) 37) CNS (central nervous system) depressants
GABA (y-aminobutyric acid); Benzodiazepines; Seizure tolerance;
Brain slices (rat)
Receptor coupling; Cl~ channels (Chang, Y.-F. (233) 209)
Baclofen; B-Phenyl-GABA; GABA, receptors; Ileum (guinea-pig);
(Agon/ip sarttia l agonist) (Ong, J. (233) 169)
Cocaine
Development; Ontogeny; Distress vocalization; Ultrasonic vocaliza-
Bronchoconstriction
tion; Tolerance; Withdrawal; Stimulants (Barr, G.A. (233) 143)
Endothelin; [Ala'*''5jendothelin-1; BQ-123; Hypertension; (Re-
ceptor subtype) (Noguchi, K. (233) 47)
Colonic motility
Stress (emotional); 5-HT,, receptor agonists; 5-HT, receptor antag-
Bulbo-spinal noradrenergic system
onists; 5-HT, receptor antagonists; (Rat) (Gué, M. (233) 193)
L-Tyrosine (methyl ester); Antinociception; 5-Opioid receptors
(Kawabata, A. (233) 255)
Contractility
Burst firing a-Tocopherol analogue (MDL 73404); Free radical scavenger;
a,-Adrenoceptors; Idazoxan; Noradrenaline; Reserpine (Grenhoff, J. Reperfusion injury; Myocardial ischaemia /reperfusion; Lipid peroxi-
(233) 79) dation (Lukovic, L. (233) 63)
Ca?* channel agonists Cough
Thaliporphine; Vasoconstrictors; Thoracic aorta (rat) (Teng, C.-M. Antitussive effect; B-Endorphin; Opioid receptors (Kamei, J. (233)
(233) 7) 251)
Ca?* channels (voltage-sensitive) Cyclosporine A
Isradipine; Cerebral ischemia; Dopamine; Microdialysis (Ooboshi, Endothelin; Smooth muscle cell (vascular); (Rat) (Takeda, Y. (233)
H. (233) 165) 299)
DAU 6285 DTG (1,3-di-(2-tolyl) guanidine)
5-HT, receptors; (Pig) (Van Meel, J.C.A. (233) 295) o Binding sites; Antipsychotics; d,l-Amphetamine; Dizocilpine; Ani-
mal models; (Rat) (Riickert, N.G.H. (233) 261)
Decavanadate
K* channels (ATP-sensitive); Ventricular cells (single); Patch clamp EDTA
(Nakashima, H. (233) 219) EGTA; Gastric acid secretion; Ethanol; Gastric ulcer; Pepsin; Stress
(Glavin, G.B. (233) 269)
Depolarization block
EGTA
Neuroleptics; Dopamine release; Dopamine metabolism; 3-
EDTA; Gastric acid secretion; Ethanol; Gastric ulcer; Pepsin; Stress
Methoxytyramine; Striatum; Nucleus accumbens; Frontal cortex;
(Glavin, G.B. (233) 269)
(Rat) (Chrapusta, S.J. (233) 135)
Ejaculation
Development
Sexual behaviour; Castration; 8-OH-DPAT (8-hydroxy-2-(di-n-pro-
Ontogeny; Distress vocalization; Ultrasonic vocalization; Tolerance;
pylamino)tetralin); Testosterone; (Wistar rat) (Haensel, S.M. (233)
Withdrawal; Cocaine; Stimulants (Barr, G.A. (233) 143)
187)
Diethy!stilbestrol Elecirical field stimulation
Steroids; Myometrium; Uterine artery; Estrogen; Progesterone Cholinergic neurotransmission; Muscarinic M, receptors; Muscarinic
(Kostrzewska, A. (233) 127) M, receptors; Trachea (guinea-pig); Muscarinic receptor antagonists
(Ten Berge, R.E.J. (233) 279)
Distress vocalization
Development; Ontogeny; Ultrasonic vocalization; Tolerance; With- B-Endorphin
drawal; Cocaine; Stimulants (Barr, G.A. (233) 143) Cough; Antitussive effect; Opioid receptors (Kamei, J. (233) 251)
Diuretic effects Endothelial cells
ANP (atrial natriuretic peptide); Ca** entry blockers; Verapamil; Prostacyclin; Ca** indicators; Aorta (bovine); Arachidonate
Felodipine; Nifedipine (Shamiss, A. (233) 113) metabolism (Boeynaems, J.-M. (233) 13)
Endothelin
Dizocilpine
[Ala'*!"5 jendothelin-1; BQ-123; Bronchoconstriction; Hyperten-
o Binding sites; DTG (1,3-di-(2-tolyl)guanidine); Antipsychotics; d,]
sion; (Receptor subtype) (Noguchi, K. (233) 47)
Amphetamine; Animal models; (Rat) (Riickert, N.G.H. (233) 261)
Nitric oxide (NO); Endotoxin shock; Pulmonary hypertension; Adult
1-DOPA (1-dihydroxyphenylalanine )
respiratory distress syndrome (ARDS), Noradrenaline; Neuropeptide
Somatostatin; Neuropeptide Y; Amantadine; 6-Hydroxydopamine;
Y (Weitzberg, E. (233) 85)
Bifemelane (Maeda, K. (233) 227)
Cyclosporine A; Smooth muscle cell (vascular); (Rat) (Takeda, Y
Dopamine (233) 299)
Isradipine; Cerebral ischemia; Microdialysis; Ca** channels (volt-
age-sensitive) (Ooboshi, H. (233) 165) [Ala1,3,11,15]endothelin-1
Endothelin; BQ-123; Bronchoconstriction; Hypertension; (Receptor
Dopamine metabolism subtype) (Noguchi, K. (233) 47)
Neuroleptics; Dopamine release; 3-Methoxytyramine; Striatum; Nu-
cleus accumbens; Frontal cortex; Depolarization block; (Rat) Endotoxin shock
(Chrapusta, S.J. (233) 135) Nitric oxide (NO); Pulmonary hypertension; Adult respiratory dis-
tress syndrome (ARDS); Endothelin; Noradrenaline; Neuropeptide
Dopamine D, receptor agonists Y (Weitzberg, E. (233) 85)
Dopamine D, receptor agonists; Nucleus accumbens; Oral be-
haviour; Principal factor analysis; SK&F 38393; Quinpirole (Koene, Estrogen
P. (233) 151) Steroids; Myometrium; Uterine artery; Progesterone; Diethyjistil-
bestrol (Kostrzewska, A. (233) 127)
Dopamine D, receptor agonists
Ethanol
Dopamine D, receptor agonists; Nucleus accumbens; Oral be-
EGTA; EDTA; Gastric acid secretion; Gastric ulcer; Pepsin; Stress
haviour; Principal factor analysis; SK&F 38393; Quinpirole (Koene,
P. (233) 151) (Glavin, G.B. (233) 269)
N° -Nitro-L-arginine; Angiotensin II; Noradrenaline; Vasopressor;
Dopamine D, receptors Bradycardia; Baroreflex (Wang, Y.-X. (233) 275)
Schizophrenia; Affinity states (Mamelak, M. (233) 175)
Excitability
Dopamine D, receptors y2MSH (y,-melanocyte-stimulating thhormone); ACTH-(4—10);
Aporphines; Sulpiride (Seeman, P. (233) 173) Melanotropins; Hemodynamics; Urethane anesthesia; Pentobarbital
anesthesia; (Conscious rat) (De Wildt, D.J. (233) 157)
Dopamine release
Neuroleptics; Dopamine metabolism; 3-Methoxytyramine; Striatum; Felodipine
Nucleus accumbens; Frontal cortex; Depolarization block; (Rat) ANP (atrial natriuretic peptide); Ca** entry blockers; Verapamil;
(Chrapusta, S.J. (233) 135) Nifedipine; Diuretic effects (Shamiss, A. (233) 113)
312
d-Fenfluramine Hippocampus
d-Norfenfluramine; Indole-depleting effect; (Rat) (Caccia, S. (233) JTP-2942 (N*-((1S,2R)-2-methyl-4-oxycyclopentanecarbonyl]-L-
71) histidyl-L-prolinamide); TRH (thyrotropin-releasing hormone);
Acetylcholine; Choline; Frontal cortex; Microdialysis (Toide, K. (233)
Free radical scavenger 21)
a-Tocopherol analogue (MDL 73404); Reperfusion injury; Myocar-
dial ischaemia/reperfusion; Contractility; Lipid peroxidation GABA (y-aminobutyric acid); GABA, receptors; Inhibitory post-
(Lukovic, L. (233) 63) synaptic potential (late); GABA transmission; GABA, receptor
antagonists (Olpe, H.-R. (233) 179)
Frontal cortex
JTP-2942 (N*-{(1S,2R)-2-methyl-oxycyclopentanecarbony]l}-L-histi- 5-HT (5-hydroxytryptamine, serotonin)
dyl-L-prolinamide); TRH (thyrotropin-releasing hormone); Acetyl- RP 62203; 5-HT, receptor antagonists; Autoradiography; ['*I JAMIK
choline; Choline; Hippocampus; Microdialysis (Toide, K. (233) 21) ({'*1}7-amino-8-iodo-ketanserin); [*H]Mesulergine (Maigouris, C.
(233) 29)
Neuroleptics; Dopamine release; Dopamine metabolism; 3-
Methoxytyramine; Striatum; Nucleus accumbens; Depolarization 5-HT,, receptor agonists
block; (Rat) (Chrapusta, S.J. (233) 135) Stress (emotional); 5-HT, receptor antagonists; 5-HT, receptor an-
tagonists; Colonic motility; (Rat) (Gué, M. (233) 193)
GABA (y-aminobutyric acid)
Hippocampus; GABA, receptors; Inhibitory postsynaptic potential 5-HT, receptor antagonists
(late); GABA transmission; GABA, receptor antagonists (Olpe, RP 62203; 5-HT (5-hydroxytryptamine, serotonin); Autoradiography;
H.-R. (233) 179) ['1]AMIK ({'?51}7-amino-8-iodo-ketanserin); [*H]Mesulergine
(Malgouris, C. (233) 29)
Benzodiazepines; CNS (central nervous system) depressants; Seizure
tolerance; Receptor coupling; Cl~ channels (Chang, Y.-F. (233) 209) [SHJRP 62203 binding sites; Brain autoradiography (Malgouris, C.
(233) 37)
GABA, receptor antagonists
GABA (y-aminobutyric acid); Hippocampus; GABA, receptors; Stress (emotional); 5-HT,, receptor agonists; 5-HT, receptor antag-
Inhibitory postsynaptic potential (late); GABA transmission (Olpe, onists; Colonic motility; (Rat) (Gué, M. (233) 193)
H.-R. (233) 179)
5-HT, receptor antagonists
GABA, receptors Stress (emotional), 5-HT,, receptor agonists; 5-HT, receptor antag-
Baclofen; B-Phenyl-GABA; Brain slices (rat); Ileum (guinea-pig);
onists; Colonic motility; (Rat) (Gué, M. (233) 193)
(Agonist /partial agonist) (Ong, J. (233) 169)
5-HT, receptors
GABA (y-aminobutyric acid); Hippocampus; Inhibitory postsynaptic
DAU 6285; (Pig) (Van Meel, J.C.A. (233) 295)
potential (late); GABA transmission; GABA, receptor antagonists
(Olpe, H.-R. (233) 179)
6-Hydroxydopamine
Somatostatin; Neuropeptide Y; |-DOPA (I-dihydroxyphenylalanine),;
GABA transmission
Amantadine; Bifemelane (Maeda, K. (233) 227)
GABA (y-aminobutyric acid); Hippocampus; GABA, receptors;
Inhibitory postsynaptic potential (late); GABA , receptor antagonists
(Olpe, H.-R. (233) 179) Hypertension
Endothelin; [Ala'*-'!:'> jendothelin-1; BQ-123; Bronchoconstriction;
(Receptor subtype) (Noguchi, K. (233) 47)
Gastric acid secretion
EGTA; EDTA; Ethanol; Gastric ulcer; Pepsin; Stress (Glavin, G.B.
(233) 269) Hypoxia
21-Aminosteroids; NMDA (N-methyl-D-aspartate); Lipid peroxida-
Gastric fundus (rat) tion (Domenici, M.R. (233) 291)
Tachykinin; NK, receptors; Radioligand binding; Neurokinin A;
NeJuemrroopneepnttiiddee 5 y (Buurrcchheerr, E.> 4(922323)) 220011)) Idazoxan
a,-Adrenoceptors; Burst firing; Noradrenaline; Reserpine (Gren-
Gastric ulcer hoff, J. (233) 79)
EGTA; EDTA; Gastric acid secretion; Ethanol; Pepsin; Stress
(Glavin, G.B. (233) 269) lleum (guinea-pig)
Baclofen; B-Phenyl-GABA; GABA, receptors; Brain slices (rat);
Glucose (Agonist /partial agonist) (Ong, J. (233) 169)
Islets of Langerhans; Monoamine oxidase activity; a-Adrenoceptor
stimulation; B-Adrenoceptor stimulation; Cholinergic stimulation; Indole-depleting effect
Insulin; (Mouse) (Panagiotidis, G. (233) 285) d-Fenfluramine; d-Norfenfluramine; (Rat) (Caccia, S$. (233) 71)
Hemodynamics Inhibitory postsynaptic potential (late)
Y¥2MSH (y>-melanocyte-stimulating hormone); ACTH-(4-10); GABA (y-aminobutyric acid); Hippocampus; GABA, receptors;
Melanotropins; Urethane anesthesia; Pentobarbital anesthesia; Ex- GABA transmission; GABA, receptor antagonists (Olpe, H.-R.
citability; (Conscious rat) (De Wildt, D.J. (233) 157) (233) 179)
Insulin Microcirculation
Islets of Langerhans; Monoamine oxidase activity; a-Adrenoceptor Big endothelin-1; Big endothelin-3; Phosphoramidon; Cheek pouch
stimulation; B-Adrenoceptor stimulation; Cholinergic stimulation; (hamster); Skin blood flow (rat) (Lawrence, E. (233) 243)
Glucose; (Mouse) (Panagiotidis, G. (233) 285)
Microdialysis
Interleukin-1 JTP-2942 (N*-((1S,2R)-2-methyl-4-oxycyclopentanecarbonyl]-L-
Interleukin-6; Interleukin receptors; Smooth muscle (vascular); Phy- histidyl-L-prolinamide); TRH (thyrotropin-releasing hormone);
coerythrin (French, J.F. (233) 109) Acetylcholine; Choline; Frontal cortex; Hippocampus (Toide, K.
(233) 21)
Tumour necrosis factor; Stomach (Montuschi, P. (233) 303)
Isradipine; Cerebral ischemia; Dopamine; Ca** channels (voltage-
Interleukin-6 sensitive) (Ooboshi, H. (233) 165)
Interleukin-1; Interleukin receptors; Smooth muscle (vascular), Phy-
coerythrin (French, J.F. (233) 109) MK-801
Postischemic recovery; Postischemic survival; Ischemia (forebrain);
Interleukin receptors (Mongolian gerbil) (Von Lubitz, D.K_J.E. (233) 95)
Interleukin-1; Interleukin-6; Smooth muscle (vascular); Phycoery-
thrin (French, J.F. (233) 109) Monoamine oxidase activity
Islets of Langerhans; a-Adrenoceptor stimulation; B-Adrenoceptor
Ischemia (forebrain) stimulation; Cholinergic stimulation; Insulin; Glucose; (Mouse) (Pan-
MK-801; Postischemic recovery; Postischemic survival; (Mongolian agiotidis, G. (233) 285)
gerbil) (Von Lubitz, D.K_J.E. (233) 95)
Y,-MSH (y,-melanocyte-stimulating hormone)
Islets of Langerhans ACTH4~4-10); Melanotropins; Hemodynamics; Urethane anesthesia;
Monoamine oxidase activity; a-Adrenoceptor stimulation; B-Adren- Pentobarbital anesthesia; Excitability; (Conscious rat) (De Wildt, D_J.
oceptor stimulation; Cholinergic stimulation; Insulin; Glucose; (233) 157)
(Mouse) (Panagiotidis, G. (233) 285)
Muscarinic receptor antagonists
Isradipine Cholinergic neurotransmission; Muscarinic M, receptors; Muscarinic
Cerebral ischemia; Dopamine; Microdialysis; Ca** channels (volt M, receptors; Trachea (guinea-pig); Electrical field stimulation
age-sensitive) (Ooboshi, H. (233) 165) (Ten Berge, R.E.J. (233) 279)
JTP-2942 (N*-[(1S,2R)-2-methyl-4-oxycyclopentanecarbony!-]L - Muscarinic M, receptors
histidyl-L-prolinamide ) Cholinergic neurotransmission; Muscarinic M, receptors; Trachea
TRH (thyrotropin-releasing hormone); Acetylcholine; Choline; (guinea-pig); Muscarinic receptor antagonists; Electrical field stimu-
Frontal cortex; Hippocampus; Microdialysis (Toide, K. (233) 21) lation (Ten Berge, R.E.J. (233) 279)
K~* channels (ATP-sensitive) Muscarinic M , receptors
Decavanadate; Ventricular cells (single); Patch clamp (Nakashima, Cholinergic neurotransmission; Muscarinic M, receptors; Trachea
H. (233) 219) (guinea-pig); Muscarinic receptor antagonists; Electrical field stimu-
lation (Ten Berge, R.E.J. (233) 279)
Lipid peroxidation
a-Tocopherol analogue (MDL 73404); Free radical scavenger; Myenteric plexus
Reperfusion injury; Myocardial ischaemia /reperfusion; Contractility OP-41483 (prostacyclin analog); Acetylcholine release; Prostaglandin
(Lukovic, L. (233) 63) release (Fukunaga, Y. (233) 237)
21-Aminosteroids; NMDA (N-methyl-D-aspartate); Hypoxia Myocardial ischaemia /reperfusion
(Domenici, M.R. (233) 291) a-Tocopherol analogue (MDL 73404), Free radical scavenger;
Reperfusion injury; Contractility; Lipid peroxidation (Lukovic, L
Melanotropins (233) 63)
¥2MSH (y,-melanocyte-stimulating hormone); ACTH-~(4-10);
Hemodynamics; Urethane anesthesia; Pentobarbital anesthesia; Ex- Myometrium
citability; (Conscious rat) (De Wildt, DJ. (233) 157) Steroids; Uterine artery; Estrogen; Progesterone; Diethyistilbestroi
(Kostrzewska, A. (233) 127)
[>H] Mesulergine
RP 62203; 5-HT, receptor antagonists; 5-HT (S5-hydroxytryptamine, Neurokinin A
serotonin); Autoradiography; ['*IJAMIK ({!*°I}7-amino-8-iodo- Tachykinin; NK, receptors; Radioligand binding; Neuropeptide y;
ketanserin) (Malgouris, C. (233) 29) Gastric fundus (rat) (Burcher, E. (233) 201)
Metabolism Neuroleptics
p-Opioid receptors; 5-Opioid receptors; Antinociception; Opioid Dopamine release; Dopamine metabolism; 3-Methoxytyramine;
receptor antagonists (Horan, PJ. (233) 53) Striatum; Nucleus accumbens; Frontal cortex; Depolarization block;
(Rat) (Chrapusta, S.J. (233) 135)
3-Methoxytyramine
Neuroleptics; Dopamine release; Dopamine metabolism; Striatum; Neuropeptide y
Nucleus accumbens; Frontal cortex; Depolarization block; (Rat) Tachykinin; NK, receptors; Radioligand binding; Neurokinin A;
(Chrapusta, S.J. (233) 135) Gastric fundus (rat) (Burcher, E. (233) 201)
314
Neuropeptide Y Opioid receptor antagonists
Nitric oxide (NO); Endotoxin shock; Pulmonary hypertension; Adult u-Opioid receptors; 5-Opioid receptors; Antinociception; Metabo-
respiratory distress syndrome (ARDS); Endothelin; Noradrenaline lism (Horan, P.J. (233) 53)
(Weitzberg, E. (233) 85)
Opioid receptors
Somatostatin; |-DOPA (l-dihydroxyphenylalanine); Amantadine; 6- Cough; Antitussive effect; 8-Endorphin (Kamei, J. (233) 251)
Hydroxydopamine; Bifemelane (Maeda, K. (233) 227)
5-Opioid receptors
Neuroprotection pu-Opioid receptors; Antinociception; Opioid receptor antagonists;
Taxol neuropathy; ORG 2766 (Hamers, F.P.T. (233) 177) Metabolism (Horan, P.J. (233) 53)
Nifedipine L-Tyrosine (methyl ester); Antinociception; Bulbo-spinal noradre-
ANP (atrial natriuretic peptide); Ca** entry blockers; Verapamil; nergic system (Kawabata, A. (233) 255)
Felodipine; Diuretic effects (Shamiss, A. (233) 113)
pu -Opioid receptors
Nitric oxide (NO) 5-Opioid receptors; Antinociception; Opioid receptor antagonists;
Endotoxin shock; Pulmonary hypertension; Adult respiratory distress Metabolism (Horan, P.J. (233) 53)
syndrome (ARDS); Endothelin; Noradrenaline; Neuropeptide Y
(Weitzberg, E. (233) 85) OP-41483 (prostacyclin analog)
Acetylcholine release; Prostaglandin release; Myenteric plexus
Nitric oxide synthase (Fukunaga, Y. (233) 237)
Aminoguanidine; Selective inhibitor inducible (Misko, T.P. (233)
Oral behaviour
119)
Dopamine D, receptor agonists; Dopamine D, receptor agonists;
N®&- Nitro-L-arginine Nucleus accumbens; Principal factor analysis; SK&F 38393; Quinpi-
role (Koene, P. (233) 151)
Ethanol; Angiotensin II; Noradrenaline; Vasopressor; Bradycardia;
Baroreflex (Wang, Y.-X. (233) 275)
ORG 2766
Taxol neuropathy; Neuroprotection (Hamers, F.P.T. (233) 177)
NK, receptors
Tachykinin; Radioligand binding; Neurokinin A; Neuropeptide y;
Patch clamp
Gastric fundus (rat) (Burcher, E. (233) 201)
Decavanadate; K* channels (ATP-sensitive); Ventricular cells
(single) (Nakashima, H. (233) 219)
NMDA (N-methyl-D-aspartate)
21-Aminosteroids; Lipid peroxidation; Hypoxia (Domenici, M.R.
Pentobarbital anesthesia
(233) 291)
Yy2MSH (y>-melanocyte-stimulating hormone); ACTH-(4-10);
Melanotropins; Hemodynamics; Urethane anesthesia; Excitability;
Noradrenaline
(Conscious rat) (De Wildt, D.J. (233) 157)
a,-Adrenoceptors; Burst firing; Idazoxan; Reserpine (Grenhoff, J.
(233) 79)
Pepsin
EGTA; EDTA; Gastric acid secretion; Ethanol; Gastric ulcer; Stress
Nitric oxide (NO); Endotoxin shock; Pulmonary hypertension; Adult
(Glavin, G.B. (233) 269)
respiratory distress syndrome (ARDS); Endothelin; Neuropeptide Y
(Weitzberg, E. (233) 85)
B-Phenyl-GABA
Baclofen; GABA, receptors; Brain slices (rat); Ileum (guinea-pig);
N°-Nitro-L-arginine; Ethanol; Angiotensin II; Vasopressor; Brady- (Agonist /partial agonist) (Ong, J. (233) 169)
cardia; Baroreflex (Wang, Y.-X. (233) 275)
Phosphoramidon
d-Norfenfluramine Big endothelin-1; Big endothelin-3; Microcirculation; Cheek pouch
d-Fenfluramine; Indole-depleting effect; (Rat) (Caccia, S. (233) 71) (hamster); Skin blood flow (rat) (Lawrence, E. (233) 243)
Nucleus accumbens Phycoerythrin
Neuroleptics; Dopamine release; Dopamine metabolism; 3- Interleukin-1; Interleukin-6; Interleukin receptors; Smooth muscle
Methoxytyramine; Striatum; Frontal cortex; Depolarization block; (vascular) (French, J.F. (233) 109)
(Rat) (Chrapusta, S.J. (233) 135)
Postischemic recovery
Dopamine D, receptor agonists; Dopamine D, receptor agonists; MK-801; Postischemic survival; Ischemia (forebrain); (Mongolian
Oral behaviour; Principal factor analysis; SK&F 38393; Quinpirole gerbil) (Von Lubitz, D.K.J.E. (233) 95)
(Koene, P. (233) 151)
Postischemic survival
8-OH-DPAT (8-hydroxy-2-(di-n-propy)ltaetmrialnion ) MK-801; Postischemic recovery; Ischemia (forebrain); (Mongolian
Sexual behaviour; Ejaculation; Castration; Testosterone; (Wistar rat) gerbil) (Von Lubitz, D.K.J.E. (233) 95)
(Haensel, $.M. (233) 187)
Principal factor analysis
Ontogeny Dopamine D, receptor agonists; Dopamine D, receptor agonists;
Development; Distress vocalization; Ultrasonic vocalization; Toler- Nucleus accumbens; Oral behaviour; SK&F 38393; Quinpirole
ance; Withdrawal; Cocaine; Stimulants (Barr, G.A. (233) 143) (Koene, P. (233) 151)